Dieter A. Haring
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 22, 2026
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 29, 2025
Performance Evaluation of an Automated Neurofilament Light Chain Immunoassay.
Journal: The journal of applied laboratory medicine
Published: October 10, 2025
AI-driven reclassification of multiple sclerosis progression.
Journal: Nature medicine
Published: October 29, 2024
Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 28, 2024
New strategies for confirmatory testing of secondary hypotheses on combined data from multiple trials.
Journal: Clinical trials (London, England)
Published: February 05, 2024
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: June 02, 2023
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.
Journal: Neurology and therapy
Published: April 04, 2023
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.
Journal: Neurology and therapy
Published: October 04, 2022
Author Response: Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
Journal: Neurology
Published: October 03, 2022
Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology
Published: March 15, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 10, 2022
Last Updated: 09/26/2026